Search Within

Mrinal M Gounder

Formats
  1. Meeting Abstract (119)
  2. Journal Article (98)
  3. Review (4)
  4. Guidelines (2)
  5. Research Letter (2)
  6. Book Section (1)
  7. Correspondence (1)
  8. Editorial (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (229)
  2. Sarcoma Service (229)
  3. Solid Tumor Oncology Division (229)
  4. GSK Faculty (87)
  5. Hematologic Malignancies, Division of (85)
  6. Tow Center for Developmental Oncology (TCDO) (83)

More Groups

People
  1. William Tap (78)
  2. Mary Keohan (73)
  3. Sandra D'Angelo (73)
  4. Mark Dickson (70)
  5. Ping Chi (57)
  6. Li-Xuan Qin (52)

More People

Years
  1. 2025 (6)
  2. 2024 (17)
  3. 2023 (21)
  4. 2022 (36)
  5. 2021 (16)
  6. 2020 (25)

More Years

Publications
  1. Journal of Clinical Oncology (86)
  2. Annals of Oncology (24)
  3. Clinical Cancer Research (20)
  4. Cancer (7)
  5. The Oncologist (6)
  6. European Journal of Cancer (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (88)
  2. Oxford University Press (30)
  3. American Association for Cancer Research (29)
  4. Springer (14)
  5. Elsevier Inc. (11)
  6. Nature Publishing Group (10)

More Publishers

Results (229)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Frequency of genomic biomarkers of response to immunotherapy in sarcoma
    Meeting Abstract

    Trabucco, S. E.; Ali, S. M.; Sokol, E.; Betzig Schrock, A.; Albacker, L. A.; Chung, J.; Feldman Xavier, M.; Disel, U.; Miller, V. A.; Ross, J. S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Genomic subtypes of angiosarcoma: A comprehensive genomic profiling (CGP) study
    Meeting Abstract

    Ravi, V.; Trabucco, S. E.; Gounder, M. M.; Sokol, E.; Disel, U.; Frampton, G. M.; Millis, S. Z.; Schrock, A. B.; Chung, J.; Miller, V. A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with metastatic sarcoma
    Meeting Abstract

    Kelly, C. M.; Bowler, T. G.; Munhoz, R. R.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Dholakia, R.; Condy, M. M.; Singer, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase 2 results of selinexor in advanced de-differentiated (DDLS) liposarcoma (SEAL) study: A phase 2/3, randomized, double blind, placebo controlled crossover study
    Meeting Abstract

    Gounder, M. M.; Somaiah, N.; Attia, S.; Chawla, S. P.; Villalobos, V. M.; Chmielowski, B.; Burgess, M. A.; Schwartz, G. K.; Riedel, R. F.; von Mehren, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase 1 study of MDM2 inhibitor DS-3032b in patients with well/de-differentiated liposarcoma (WD/DD LPS), solid tumors (ST) and lymphomas (L)
    Meeting Abstract

    Bauer, T. M.; Gounder, M. M.; Weise, A. M.; Schwartz, G. K.; Carvajal, R. D.; Kumar, P.; Zernovak, O.; Beck, A.; Doyle, J.; Mendell-Harary, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults: Epithelioid sarcoma cohort (NCT02601950)
    Meeting Abstract

    Gounder, M.; Schöffski, P.; Villalobos, V.; Cote, G.; Chugh, R.; Chen, T. W. W.; Jahan, T.; Loggers, E. T.; Italiano, A.; Gupta, A.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults (INI1-negative tumors cohort) (NCT02601950)
    Meeting Abstract

    Stacchiotti, S.; Blay, J. Y.; Jones, R. L.; Demetri, G. D. D.; Mir, O.; Italiano, A.; Thomas, D.; Chen, T. W. W.; Schöffski, P.; Gil, T.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adults (rhabdoid tumor cohort) (NCT02601950)
    Meeting Abstract

    Jones, R. L.; Blay, J. Y.; Agulnik, M.; Chugh, R.; Mir, O.; Italiano, A.; Thomas, D.; Gupta, A.; Jahan, T.; Cote, G.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Molecular characterization of epithelioid sarcoma (ES) tumors derived from patients enrolled in a phase II study of tazemetostat (NCT02601950)
    Meeting Abstract

    Daigle, S.; Stacchiotti, S.; Schöffski, P.; Villalobos, V.; Cote, G.; Chugh, R.; Chen, T. W. W.; Jahan, T.; Loggers, E. T.; Italiano, A.; more...
    Annals of Oncology (2018)

    Fulltext@MSK | Save
  • Sorafenib for advanced and refractory desmoid tumors
    Journal Article

    Gounder, M. M.; Mahoney, M. R.; Van Tine, B. A.; Ravi, V.; Attia, S.; Deshpande, H. A.; Gupta, A. A.; Milhem, M. M.; Conry, R. M.; Movva, S.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save